OV Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$238K Sell
2,751
-8,373
-75% -$802K 0.49% 26
2025
Q4
$1.07M Hold
11,124
0.93% 22
2025
Q3
$1.06M Buy
11,124
+28
+0.3% +$2.57K 0.9% 24
2025
Q2
$967K Sell
11,096
-16,491
-60% -$1.4M 0.81% 34
2025
Q1
$2.48M Buy
27,587
+5,833
+27% +$522K 1.16% 28
2024
Q4
$1.74M Buy
21,754
+1,697
+8% +$147K 0.81% 34
2024
Q3
$1.81M Buy
20,057
+2,821
+16% +$237K 1.2% 32
2024
Q2
$1.36M Buy
17,236
+236
+1% +$19.3K 0.95% 44
2024
Q1
$1.48M Hold
17,000
1.07% 39
2023
Q4
$1.41M Buy
+17,000
New +$1.3M 1.17% 36

Other funds holding MDT

OV Management's MDT Position: Q1 2026 in Review

OV Management reduced its Medtronic (MDT) stake by 75% in Q1 2026, selling an estimated $802K and leaving 2,751 shares worth $238K. The position accounts for 0.49% of the portfolio, ranked #26.

OV Management first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.48M in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • OV Management held 2,751 shares of Medtronic worth $238K as of Q1 2026.
  • OV Management sold 8,373 Medtronic shares in Q1 2026, an estimated $802K.
  • Medtronic made up 0.49% of OV Management's portfolio in Q1 2026, its #26 holding.
  • OV Management first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • OV Management's Medtronic position peaked at $2.48M in Q1 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on OV Management's 13F filing for Q1 2026, filed 14 Apr 2026.